Investments
Clinical Candidates
Over ten GHIT development partnerships have conducted clinical programs worldwide.
Please see
each program to know more details.
-
-
Malaria / Drug
SJ733 -
-
- Development Stage: Phase IIb Clinical Trial
- Country: Peru
-
-
-
-
Malaria / Drug
ALAQ-FDC -
-
- Development Stage: Phase III Clinical Trial, Registration
- Country: Rwanda, Uganda, Angola, Nigeria, Thailand
-
-
-
-
Malaria / Vaccine
AnAPN1 -
-
- Development Stage: Phase I Clinical Trial
- Country: Gabon (Planned)
-
-
-
-
Mycetoma / Drug
Fosravuconazole -
-
- Development Stage: Under Regulatory Submission Preparation
- Country: Sudan
-
© Purushottam Diwakar-DNDiDetails -
-
-
Cutaneous leishmaniasis / Drug
CpG-D35 -
-
- Development Stage: Phase I Clinical Trial
- Country: United Kingdom, Colombia
-
© Sydelle Willow Smith-DNDiDetails -
-
-
Lymphatic filariasis, Onchocerciasis / Drug
AWZ1066S -
-
- Development Stage: Phase I Clinical Trial
- Country: United Kingdom, Cameroon (planned)
-
Photo credit: Kate DoddDetails -
-
-
Leprosy / Vaccine
LepVax -
-
- Development Stage: Phase I Clinical Trial
- Country: Brazil
-
-
-
-
Buruli Ulcer / Diagnostics
BU-MYCOLAC -
-
- Development Stage: Product Development
- Country: Cameroon, Ivory Coast
-
Photo credit: FINDDetails -
-
-
Leishmaniasis / Diagnostics
Leishmania Skin Test (LST) -
-
- Development Stage: Product Development
- Country: India and Africa (Planned)
-
-
-
-
Schistosomiasis / Diagnostics
SCH CAA RDT -
-
- Development Stage: Product Development
- Country: Kenya, Philippines
-
-
-
-
Schistosomiasis / Pediatric Drug
Arpraziquantel -
-
- Development Stage: Registration, Access
- Country: Ivory Coast, Kenya, Uganda and other endemic countries.
-
Photo credit: SCI Foundation/UgandaDetails -